Campbell's
CPB
$20.13
-2.19%
Campbell's is a leading domestic packaged food manufacturer with a portfolio extending far beyond its iconic canned soup, encompassing snacks, simple meals, and beverages. The company is a well-established player in the consumer defensive sector, owning a stable of recognized brands including Pepperidge Farm, Goldfish, Snyder's of Hanover, and the recently acquired Rao's. The current investor narrative is dominated by concerns over deteriorating financials, a shrinking market capitalization that threatens its long-standing position in the S&P 500 index, and a debate over whether its high dividend yield represents a value opportunity or a value trap amidst these significant headwinds.…
CPB
Campbell's
$20.13
Related headlines
Investment Opinion: Should I buy CPB Today?
Rating: Hold. The core thesis is that CPB is a deeply undervalued but fundamentally challenged company, where the high dividend yield and low valuation provide a floor, but deteriorating financials and negative momentum preclude a bullish call until evidence of stabilization emerges.
Supporting evidence includes a forward P/E of 9.56x, a 39% discount to its own trailing multiple and well below sector peers, signaling extreme pessimism. The 4.77% dividend yield is supported by strong TTM free cash flow of $919 million. However, these positives are counterbalanced by a -4.51% YoY revenue decline, a 159 bps drop in net margin, and a stock price down nearly 40% in a year with no visible catalyst for reversal. Analyst sentiment is neutral-to-bearish, reflecting this lack of near-term catalysts.
The thesis would upgrade to Buy if quarterly revenue growth turns positive and gross margins stabilize above 28%, indicating the operational slide has halted. It would downgrade to Sell if the stock breaks decisively below the $19.56 support on high volume, or if free cash flow deteriorates threatening the dividend. Relative to its history and challenged peers, the stock is fairly valued to slightly undervalued, but this valuation is warranted by its poor growth profile, making it a value trap for growth investors but a potential high-yield value play for the exceptionally patient.
Sign up to view all
CPB 12-Month Price Forecast
CPB is a classic 'show me' story trading at a crisis valuation. The AI assessment is neutral due to the high degree of binary risk: the stock is either a deep value opportunity or a value trap, with the evidence currently favoring the latter. The stance would upgrade to bullish on concrete evidence of revenue stabilization and margin improvement for two consecutive quarters. It would turn bearish on a breakdown below $19.56 or any indication the dividend is unsustainable. For now, the high yield and low multiple provide a cushion, but they are not catalysts for appreciation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Campbell's's 12-month outlook, with a consensus price target around $26.17 and implied upside of +30.0% versus the current price.
Average Target
$26.17
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$16 - $26
Analyst target range
Analyst coverage is limited, with only 6 analysts providing estimates, and institutional ratings data shows a predominantly bearish to neutral sentiment. Recent actions from major firms include holds from Deutsche Bank and TD Cowen, and sells or underweight ratings from UBS, B of A Securities, and Barclays. The consensus recommendation leans heavily towards Hold/Sell, with no Buy ratings evident in the recent data, signaling very low near-term conviction. The average target price is not provided in the data, so the implied upside or downside cannot be calculated. The target price range is also not available, preventing an analysis of bull versus bear cases. The pattern of recent analyst actions shows no upgrades, only reiterations of neutral or negative ratings following the Q2 2026 earnings report in March. This limited and cautious coverage, combined with the stock's small-cap status (market cap ~$9.6B) and potential S&P 500 demotion risk, contributes to higher volatility and less efficient price discovery, making the stock suitable only for investors with high risk tolerance.
Bulls vs Bears: CPB Investment Factors
The bear case currently holds stronger evidence, anchored by concrete deterioration in revenue, margins, and stock price momentum. The bull case rests on a deep valuation discount and strong cash flow, but these are defensive traits rather than catalysts for growth. The single most important tension in the investment debate is whether CPB's current valuation and yield represent a classic value opportunity or a 'value trap' where fundamentals continue to erode despite appearing cheap. The resolution hinges entirely on whether management can stem the revenue decline and margin compression in the coming quarters.
Bullish
- Deeply Undervalued Forward P/E: The forward P/E of 9.56x is a significant discount to both the sector average (low-to-mid 20s) and its own trailing P/E of 15.98x. This suggests the market has priced in severe pessimism, creating a potential value opportunity if earnings stabilize.
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with $919 million over the trailing twelve months. This provides a solid foundation to support its 4.77% dividend yield and service its debt, mitigating near-term solvency risks.
- Oversold Technical Condition: The stock is trading just 3.2% above its 52-week low of $19.56 after a 39.67% annual decline. This extreme oversold condition, coupled with a negative beta of -0.005, indicates company-specific troubles are fully priced in, limiting near-term downside.
- High Dividend Yield as a Cushion: The current dividend yield of 4.77% provides a tangible return while investors wait for a potential turnaround. The payout ratio of 76.25% is elevated but supported by strong free cash flow.
Bearish
- Severe Revenue and Margin Contraction: Recent quarterly revenue declined 4.51% YoY to $2.564B, while gross margin compressed 254 basis points to 27.96% and net margin fell to 5.66%. This dual deterioration indicates fundamental business erosion and pricing pressure.
- Sustained Downtrend and Negative Momentum: The stock is in a pronounced downtrend, down 23.29% over three months and 39.67% over one year. It has underperformed the SPY by 31.44 percentage points in three months, showing severe negative momentum and lack of buyer conviction.
- Elevated Financial Leverage: A debt-to-equity ratio of 1.85 indicates significant leverage, which increases financial risk amid declining profitability. The current ratio of 0.77 also points to potential short-term liquidity strain.
- Risk of S&P 500 Demotion: With a shrinking market cap (~$9.6B) and deteriorating financials, the company's 67-year tenure in the S&P 500 is at serious risk, as highlighted by recent news. A demotion could trigger forced selling by index funds.
CPB Technical Analysis
The stock is in a pronounced and sustained downtrend, having declined 39.67% over the past year. With a current price of $20.58, it is trading near the bottom of its 52-week range of $19.56 to $35.00, positioning it at just 3.2% above the 52-week low. This proximity to multi-year lows suggests the stock is deeply oversold, but also indicates severe negative momentum and a lack of buyer conviction, making it a classic 'falling knife' scenario. Recent momentum remains sharply negative, with the stock down 23.29% over the past three months and 1.15% over the past month, confirming the persistence of the longer-term downtrend. The stock has demonstrated extreme negative relative strength, underperforming the SPY by 31.44 percentage points over three months, highlighting its severe weakness even in a rising market. Key technical support is clearly defined at the 52-week low of $19.56, while resistance sits at the recent breakdown level near $30 from late 2025. A breakdown below $19.56 would signal a continuation of the bearish trend, while any recovery would need to reclaim the $26-$28 zone to suggest a potential base is forming. The stock's beta of -0.005 indicates it has moved inversely and with near-zero correlation to the broader market, which is highly unusual and reflects its company-specific troubles.
Beta
-0.01
-0.01x market volatility
Max Drawdown
-47.2%
Largest decline past year
52-Week Range
$20-$35
Price range past year
Annual Return
-39.9%
Cumulative gain past year
| Period | CPB Return | S&P 500 |
|---|---|---|
| 1m | -2.4% | +5.1% |
| 3m | -24.0% | +8.3% |
| 6m | -33.4% | +10.4% |
| 1y | -39.9% | +29.6% |
| ytd | -27.4% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CPB Fundamental Analysis
Revenue growth has turned negative, with the most recent quarterly revenue of $2.564 billion representing a 4.51% year-over-year decline. This contraction follows a multi-quarter trend of decelerating growth, as revenue has fallen from $2.772 billion in Q1 2025 to the current level, indicating mounting top-line pressure. Segment data shows Baked Snacks contributed $995 million, Soups $821 million, and Beverages $748 million, but without growth rates, the specific drivers of the decline are unclear. The company remains profitable but margins are under significant pressure; net income for the quarter was $145 million, yielding a net margin of 5.66%, which is down from 7.25% in the prior-year quarter. Gross margin compressed to 27.96% from 30.50% a year ago, reflecting inflationary cost pressures and potentially weaker pricing power. Operating income of $272 million resulted in an operating margin of 10.61%, also down from the prior year's 13.18%. The balance sheet shows elevated financial leverage with a debt-to-equity ratio of 1.85, indicating significant debt usage. However, the company generates substantial cash flow, with free cash flow over the trailing twelve months at $919 million, providing coverage for its dividend and debt obligations. The current ratio of 0.77 suggests potential short-term liquidity strain, though a return on equity of 15.43% indicates management is still generating acceptable returns on shareholder capital.
Quarterly Revenue
$2.6B
2026-02
Revenue YoY Growth
-0.04%
YoY Comparison
Gross Margin
+0.27%
Latest Quarter
Free Cash Flow
$919000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CPB Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 15.98x, while the forward PE is significantly lower at 9.56x, indicating the market expects a significant rebound in earnings over the next year. The gap suggests either depressed current earnings are expected to recover or that forward estimates may be overly optimistic given recent trends. Compared to the Consumer Defensive sector, Campbell's trailing PE of 15.98x is at a discount to typical packaged food peers, which often trade in the low-to-mid 20s, reflecting the market's discount for its growth challenges and financial deterioration. This discount appears justified by the company's negative revenue growth and margin compression, which are worse than many stable sector peers. Historically, the stock's current trailing PE of 15.98x is near the lower end of its own range over the past two years, which has seen PEs as high as 40.46x and as low as negative during a loss-making quarter. Trading near historical lows suggests the market has priced in a significant amount of bad news, potentially creating a value opportunity if the fundamentals stabilize, but also risks a value trap if the deterioration continues.
PE
16.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -1164x~40x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company faces a deteriorating profit profile, with net margin falling from 7.25% to 5.66% year-over-year and gross margin compressing by 254 basis points. Revenue has turned negative, declining 4.51% YoY, indicating top-line pressure in its core categories. Elevated financial leverage, with a debt-to-equity ratio of 1.85, compounds these risks, as interest expenses consume earnings during a period of margin pressure. The low current ratio of 0.77 suggests potential liquidity constraints, though substantial free cash flow generation of $919 million provides a partial offset.
Market & Competitive Risks center on its valuation and status. Trading at a forward P/E of 9.56x, CPB is at a steep discount to packaged food peers, but this discount reflects justified concerns over its growth profile and may compress further if earnings estimates are cut. The looming risk of demotion from the S&P 500, following the precedent of Lamb Weston, could trigger significant technical selling from passive funds. Its unusual beta of -0.005 indicates it is moving on purely company-specific news, disconnected from broader market trends, which increases idiosyncratic volatility and reduces its defensive utility.
Worst-Case Scenario involves a continuation of the current downtrend without a fundamental catalyst. This would entail another quarterly revenue miss and guidance cut, leading to further analyst downgrades and a loss of dividend sustainability confidence. A breakdown below the key $19.56 support level could trigger a wave of stop-loss selling. In this adverse scenario, the stock could realistically revisit its 52-week low and potentially test levels 15-20% below the current price, implying a downside of -$3 to -$4 per share from $20.58, or a loss of approximately -15% to -20%.
FAQ
The key risks are, in order of severity: 1) Fundamental Deterioration Risk: Continued revenue decline and margin compression, as seen in the recent -4.51% YoY sales drop and 254 bps gross margin compression. 2) Technical & Structural Risk: Potential demotion from the S&P 500 index, which could trigger forced selling, and a stock price that remains in a severe downtrend. 3) Financial Risk: Elevated debt (Debt/Equity of 1.85) and a weak current ratio (0.77) amid declining profitability. 4) Dividend Sustainability Risk: Although currently covered by cash flow, a further earnings decline could pressure the 76.25% payout ratio.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $21 and $25, as it remains range-bound with no major catalysts. The Bull Case (20% probability) targets $28 to $32 on a successful operational turnaround and re-rating. The Bear Case (20% probability) warns of a drop to $17-$19.50 if financials worsen or the dividend is cut. The Base Case is most likely, assuming the current challenging trends persist without dramatic improvement or further collapse. The key assumption is that management can at least stabilize the business, preventing a bear-case scenario.
CPB appears statistically undervalued. Its forward P/E of 9.56x is a steep discount to the consumer defensive sector average (often in the low-to-mid 20s) and represents a 40% discount to its own trailing P/E of 15.98x. However, this discount is justified by its deteriorating fundamentals. The market is pricing in no growth and significant execution risk. Therefore, while the stock is cheap on a multiple basis, it may be fairly valued or even a 'value trap' given its current operational challenges.
CPB is a speculative buy only for a specific type of investor. With a forward P/E of 9.56x and a 4.77% dividend yield, it offers deep value and high income. However, this comes with substantial risk, including a -4.51% revenue decline, severe margin compression, and a stock in a sustained downtrend. It could be a good buy for a highly patient, contrarian income investor willing to accept volatility and potential further downside for the yield and long-term turnaround potential. It is not a good buy for growth-oriented or risk-averse investors.
CPB is strictly a long-term investment for investors with a 3-5 year horizon. The stock's high volatility (beta of -0.005 shows idiosyncratic moves), lack of near-term growth catalysts, and deep value nature mean a recovery will take multiple quarters, if it occurs. The 4.77% dividend yield also favors a longer holding period to realize its income benefit. It is unsuitable for short-term trading due to its negative momentum, low liquidity relative to large caps, and high risk of adverse news flow (e.g., S&P 500 demotion talk) causing sharp, unpredictable moves.